“Exploring the potential of Beta- 2 Agonist, Salbutamol Against Muscle Atrophy Using Computational Approach” (2022) Journal of Pharmaceutical Negative Results, 13, pp. 2709–2718. doi:10.47750/pnr.2022.13.S05.417.